U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828405) titled 'Genes, Soy Isoflavones, and Virus' on Sept. 14.
Brief Summary: In this study, we will assess whether children without established asthma who have a variation in the switch for the PAI-1 gene will have higher PAI-1 levels and remodeling / allergic inflammatory pathways in their airways than children who do not have the gene. We will also determine if soy isoflavones given when presenting for an acute respiratory illness can decrease these changes.
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Wheezing
Intervention:
DRUG: Soy Isoflavone Nutritional Supplements
Soy isoflavone will be administered orally at a d...